- Home
- GILT vs ESPR Comparison
GILT vs ESPR Comparison
Compare GILT & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GILT
- ESPR
- Stock Information
- Founded
- GILT 1987
- ESPR 2008
- Country
- GILT Israel
- ESPR United States
- Employees
- GILT N/A
- ESPR N/A
- Industry
- GILT Radio And Television Broadcasting And Communications Equipment
- ESPR Biotechnology: Pharmaceutical Preparations
- Sector
- GILT Technology
- ESPR Health Care
- Exchange
- GILT Nasdaq
- ESPR Nasdaq
- Market Cap
- GILT 429.7M
- ESPR 437.5M
- IPO Year
- GILT 1993
- ESPR 2013
- Fundamental
- Price
- GILT $9.65
- ESPR $2.21
- Analyst Decision
- GILT Strong Buy
- ESPR Buy
- Analyst Count
- GILT 2
- ESPR 6
- Target Price
- GILT $11.00
- ESPR $6.50
- AVG Volume (30 Days)
- GILT 859.6K
- ESPR 5.0M
- Earning Date
- GILT 08-06-2025
- ESPR 08-05-2025
- Dividend Yield
- GILT N/A
- ESPR N/A
- EPS Growth
- GILT 12.49
- ESPR N/A
- EPS
- GILT 0.39
- ESPR N/A
- Revenue
- GILT $349,746,000.00
- ESPR $268,125,000.00
- Revenue This Year
- GILT $42.88
- ESPR $10.59
- Revenue Next Year
- GILT $13.26
- ESPR N/A
- P/E Ratio
- GILT $25.32
- ESPR N/A
- Revenue Growth
- GILT 19.67
- ESPR N/A
- 52 Week Low
- GILT $4.30
- ESPR $0.69
- 52 Week High
- GILT $10.09
- ESPR $3.94
- Technical
- Relative Strength Index (RSI)
- GILT 66.93
- ESPR 72.60
- Support Level
- GILT $9.29
- ESPR $2.13
- Resistance Level
- GILT $10.09
- ESPR $2.24
- Average True Range (ATR)
- GILT 0.31
- ESPR 0.12
- MACD
- GILT 0.06
- ESPR -0.00
- Stochastic Oscillator
- GILT 75.71
- ESPR 81.82
About GILT Gilat Satellite Networks Ltd.
Gilat Satellite Networks Ltd is a provider of satellite-based broadband communications. The company designs and manufactures ground-based satellite communications equipment and provides comprehensive solutions and end-to-end services. Its portfolio includes a cloud-based satellite network platform, very small aperture terminals (VSATs), amplifiers, high-speed modems, on-the-move antennas and high-power solid-state power amplifiers (SSPAs), block-up converters (BUCs), and Transceivers. The company's solutions support multiple applications with a full portfolio of products to address key applications including broadband access, cellular backhaul, enterprise, in-flight connectivity, maritime, trains, defense, and public safety.
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.